[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4007 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. R. 4007
To unfreeze and release funding for grant agreements of the National
Institutes of Health, prohibit termination of such agreements for
active and ongoing research, require the inclusion of termination
clauses in such agreements, and prohibit termination of such agreements
for no longer effectuating program goals or agency priorities.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
June 12, 2025
Mrs. Watson Coleman (for herself, Mr. Thompson of Mississippi, Mr.
Lynch, Mr. Johnson of Georgia, Mr. Fields, Ms. Sewell, Ms. Norton, Ms.
Schakowsky, Ms. Titus, Ms. Tlaib, Mr. Doggett, Ms. Pettersen, Mrs.
Cherfilus-McCormick, Ms. Scholten, Mr. Bell, Mr. Keating, Ms. Lee of
Pennsylvania, Mrs. Dingell, Ms. Moore of Wisconsin, Mr. Moulton, Mr.
Pocan, Mr. Latimer, Mr. Garcia of California, Mr. Davis of Illinois,
Mrs. McIver, Ms. Barragan, Mr. Veasey, Mr. Garcia of Illinois, Mrs.
Hayes, Mr. Landsman, Mrs. Beatty, Ms. Lofgren, Mr. Carter of Louisiana,
Mr. Mfume, Mrs. Fletcher, Ms. Matsui, Mr. Magaziner, Mr. Stanton, Mr.
Mullin, Ms. Ocasio-Cortez, Mr. Larson of Connecticut, Ms. Kelly of
Illinois, and Mr. Swalwell) introduced the following bill; which was
referred to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To unfreeze and release funding for grant agreements of the National
Institutes of Health, prohibit termination of such agreements for
active and ongoing research, require the inclusion of termination
clauses in such agreements, and prohibit termination of such agreements
for no longer effectuating program goals or agency priorities.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Prevent Halting of Active Research
Act of 2025'' or the ``PHARA Act of 2025''.
SEC. 2. RELEASING NIH GRANT FUNDING.
The Secretary of Health and Human Services, acting through the
Director of the National Institutes of Health (in this section referred
to as the ``Secretary'')--
(1) shall, immediately after the date of the enactment of
this Act, with respect to a grant agreement or cooperative
agreement entered into by the Secretary--
(A) release and expend all funding to the extent
required by such agreement; and
(B) otherwise fully implement such agreement;
(2) shall, as rapidly as possible after the date of the
enactment of this Act, pay all pending reimbursement requests
owed by the Secretary under the agreements described in
paragraph (1); and
(3) may not cancel any agreement described in paragraph (1)
under which an awardee is performing active and ongoing
research.
SEC. 3. INCLUSION OF TERMINATION CLAUSES IN NIH GRANT AGREEMENTS AND
COOPERATIVE AGREEMENTS.
Any grant agreement or cooperative agreement from the National
Institutes of Health that is entered into after the date of the
enactment of this Act shall include a termination clause. Such clause
shall specify that the agreement may only be terminated in cases of
material breach, change in circumstances, or mutual agreement of all
parties, provided that--
(1) the terminating party invoking such clause submits to
all non-terminating parties a written notice of the intent to
terminate at least 90 days before the date of termination; and
(2) before the date of termination, the terminating party
attempts to amend the terms of the grant agreement or
cooperative agreement with each non-terminating party.
SEC. 4. NO TERMINATION OF NIH GRANT AGREEMENTS OR COOPERATIVE
AGREEMENTS FOR NO LONGER EFFECTUATING PROGRAM GOALS OR
AGENCY PRIORITIES.
(a) In General.--The National Institutes of Health may not
terminate, in whole or in part, a grant agreement or cooperative
agreement that is entered into after the date of the enactment of this
Act on the basis of such agreement no longer effectuating the program
goals or agency priorities.
(b) Regulatory Revision.--The Secretary of Health and Human
Services, acting through the Director of the National Institutes of
Health, shall revise section 200.340(a) of title 2, Code of Federal
Regulations, in order to comply with subsection (a) of this section.
<all>